Free Trial

Innovative Eyewear (LUCY) Competitors

Innovative Eyewear logo
$6.18 +0.06 (+0.98%)
(As of 12/11/2024 ET)

LUCY vs. MODD, APT, NXL, ICAD, CTSO, LUCD, NTRB, CLGN, BLAC, and COCH

Should you be buying Innovative Eyewear stock or one of its competitors? The main competitors of Innovative Eyewear include Modular Medical (MODD), Alpha Pro Tech (APT), Nexalin Technology (NXL), iCAD (ICAD), Cytosorbents (CTSO), Lucid Diagnostics (LUCD), Nutriband (NTRB), CollPlant Biotechnologies (CLGN), Bellevue Life Sciences Acquisition (BLAC), and Envoy Medical (COCH). These companies are all part of the "medical equipment" industry.

Innovative Eyewear vs.

Modular Medical (NASDAQ:MODD) and Innovative Eyewear (NASDAQ:LUCY) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, community ranking, earnings, media sentiment, profitability, analyst recommendations, institutional ownership, valuation and dividends.

Innovative Eyewear has higher revenue and earnings than Modular Medical. Modular Medical is trading at a lower price-to-earnings ratio than Innovative Eyewear, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Modular MedicalN/AN/A-$17.47M-$0.63-2.63
Innovative Eyewear$1.56M9.66-$6.66M-$9.66-0.64

Modular Medical has a net margin of 0.00% compared to Innovative Eyewear's net margin of -514.01%. Innovative Eyewear's return on equity of -115.86% beat Modular Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Modular MedicalN/A -246.01% -191.95%
Innovative Eyewear -514.01%-115.86%-105.40%

Modular Medical presently has a consensus price target of $5.00, indicating a potential upside of 201.20%. Innovative Eyewear has a consensus price target of $20.00, indicating a potential upside of 223.62%. Given Innovative Eyewear's higher probable upside, analysts plainly believe Innovative Eyewear is more favorable than Modular Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Modular Medical
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Innovative Eyewear
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

27.5% of Modular Medical shares are held by institutional investors. Comparatively, 1.0% of Innovative Eyewear shares are held by institutional investors. 32.3% of Modular Medical shares are held by insiders. Comparatively, 6.4% of Innovative Eyewear shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Modular Medical has a beta of 0.46, indicating that its share price is 54% less volatile than the S&P 500. Comparatively, Innovative Eyewear has a beta of 2.53, indicating that its share price is 153% more volatile than the S&P 500.

In the previous week, Modular Medical had 2 more articles in the media than Innovative Eyewear. MarketBeat recorded 3 mentions for Modular Medical and 1 mentions for Innovative Eyewear. Innovative Eyewear's average media sentiment score of 1.92 beat Modular Medical's score of 1.45 indicating that Innovative Eyewear is being referred to more favorably in the news media.

Company Overall Sentiment
Modular Medical Positive
Innovative Eyewear Very Positive

Modular Medical and Innovative Eyewear both received 2 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
Modular MedicalOutperform Votes
2
100.00%
Underperform Votes
No Votes
Innovative EyewearOutperform Votes
2
100.00%
Underperform Votes
No Votes

Summary

Innovative Eyewear beats Modular Medical on 8 of the 13 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LUCY vs. The Competition

MetricInnovative EyewearOphthalmic goods IndustryMedical SectorNASDAQ Exchange
Market Cap$15.09M$11.34B$5.26B$9.28B
Dividend YieldN/A1.63%5.12%3.95%
P/E Ratio-0.6433.93135.4217.64
Price / Sales9.664.731,236.47141.09
Price / CashN/A17.4235.5735.65
Price / Book0.723.404.824.95
Net Income-$6.66M$235.23M$119.12M$225.72M
7 Day Performance-8.44%-2.75%1.53%1.51%
1 Month Performance-10.95%-3.90%-0.54%4.96%
1 Year Performance-30.72%9.00%33.11%29.01%

Innovative Eyewear Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LUCY
Innovative Eyewear
2.7035 of 5 stars
$6.18
+1.0%
$20.00
+223.6%
-38.2%$15.09M$1.56M-0.649Positive News
Gap Up
MODD
Modular Medical
3.7026 of 5 stars
$1.65
-2.5%
$5.00
+203.4%
+1.2%$58.63MN/A-2.6239Short Interest ↓
APT
Alpha Pro Tech
N/A$5.21
-3.2%
N/A+7.3%$57.31M$61.23M14.54120
NXL
Nexalin Technology
1.1796 of 5 stars
$4.29
-1.6%
$3.00
-30.1%
+716.2%$55.17M$110,000.000.003Short Interest ↓
ICAD
iCAD
0.4404 of 5 stars
$1.92
+10.3%
N/A+31.3%$50.96M$17.32M-14.9267Short Interest ↑
High Trading Volume
CTSO
Cytosorbents
1.5147 of 5 stars
$0.91
-0.8%
$2.00
+121.0%
-27.2%$49.49M$36.35M-2.53186Analyst Forecast
Short Interest ↑
News Coverage
Gap Up
LUCD
Lucid Diagnostics
2.4118 of 5 stars
$0.81
-3.6%
$3.63
+347.5%
-44.3%$48.07M$2.43M-0.7470Analyst Forecast
Short Interest ↑
Gap Up
High Trading Volume
NTRB
Nutriband
0.9758 of 5 stars
$4.23
+2.7%
N/A+60.9%$47.00M$2.09M-5.8010Gap Down
CLGN
CollPlant Biotechnologies
3.3946 of 5 stars
$4.09
+2.3%
$12.50
+205.6%
-21.4%$46.83M$10.96M0.0070Negative News
Gap Up
BLAC
Bellevue Life Sciences Acquisition
N/A$11.32
-2.4%
N/A+8.1%$45.73MN/A0.00N/A
COCH
Envoy Medical
3.2501 of 5 stars
$2.24
+1.8%
$8.00
+257.1%
+2.3%$45.36M$320,000.000.0034Short Interest ↓

Related Companies and Tools


This page (NASDAQ:LUCY) was last updated on 12/12/2024 by MarketBeat.com Staff
From Our Partners